Butyric Acid (C4)

Butyric acid (C4) is a short-chain fatty acid produced by beneficial gut bacteria that serves as the primary fuel source for colonocytes. It activates G-protein coupled receptors GPR41 and GPR109A to reduce inflammation and strengthen intestinal barrier function.

Category: Other Evidence: 6/10 Tier: Tier 3 (preliminary)
Butyric Acid (C4) — Hermetica Encyclopedia

Origin & History

Butyric Acid, or C4, is a short-chain fatty acid found in butter and other dairy products. It is produced through bacterial fermentation in the gut.

Historical & Cultural Context

Butyric acid has been recognized for its gut health benefits, with traditional diets rich in fermented foods.

Health Benefits

- Supports gut health by nourishing colon cells, promoting a healthy digestive tract. This can lead to improved nutrient absorption and regularity. - May reduce inflammation in the gut by inhibiting inflammatory pathways, which can alleviate symptoms of inflammatory bowel diseases. - Supports metabolic health by enhancing insulin sensitivity, which can help regulate blood sugar levels. - Enhances mental health by producing short-chain fatty acids that influence neurotransmitter production, potentially improving mood and cognitive function. - Supports weight management by promoting satiety, leading to reduced calorie intake. - May improve liver health by aiding in the detoxification process, promoting overall liver function. - Supports immune function by maintaining a balanced gut microbiome, which is crucial for overall immune health.

How It Works

Butyric acid binds to G-protein coupled receptors GPR41, GPR43, and GPR109A on intestinal epithelial cells and immune cells. It inhibits histone deacetylase (HDAC) enzymes, promoting anti-inflammatory gene expression and T-regulatory cell differentiation. Additionally, it serves as the primary energy substrate for colonocytes through beta-oxidation pathways.

Scientific Research

Research, including in vitro and animal studies, supports its role in gut health and inflammation. Human studies are ongoing.

Clinical Summary

Human studies on butyric acid supplementation are limited, with most evidence derived from observational studies measuring fecal butyrate levels. Small trials (n=20-50) using sodium butyrate enemas in ulcerative colitis patients showed modest improvements in inflammation markers. Animal studies demonstrate stronger evidence for metabolic benefits, but human clinical data remains preliminary. Most research focuses on butyrate-producing probiotics rather than direct supplementation.

Nutritional Profile

- Contains 4 carbon atoms in its chain. - Naturally produced in the gut by fermentation. - Found in small amounts in butter and cheese.

Preparation & Dosage

Typically consumed through dietary sources or supplements. Dosage varies; consult a healthcare provider before use.

Synergy & Pairings

Probiotics, Omega-3, Fiber

Safety & Interactions

Oral butyric acid supplements may cause gastrointestinal upset, nausea, and strong odor due to the compound's volatile nature. High doses above 300mg daily may lead to diarrhea or abdominal cramping in sensitive individuals. No significant drug interactions have been reported, though it may enhance the effects of anti-inflammatory medications. Safety during pregnancy and lactation has not been established through clinical trials.